This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Medical, Global Crossing: Small-Cap Winners

NEW YORK ( TheStreet) -- Small-caps were rallying Monday on a flurry of deal activity. Shares of American Medical Systems (AMMD) were soaring 32% to $29.47 on volumes nearing 30 million in forenoon trading, after Endo Pharmaceuticals (ENDP) said it will acquire the incontinence drug manufacturer for $2.9 billion or $30 per share.

Communication solutions provider Global Crossing (GLBC) saw its stock jump 57% to $23.40 after Level3 Global Communications (LVLT) agreed to acquire the company for $1.9 billion or $23.04 per share. The deal will combine two unprofitable companies with total revenue of $6.26 billion as of last year, and cut annualized capital spending by about $40 million, according to the statement.

Flower Foods (FLO) picked up Tasty Baking Company (TSTY) for $4 a share, or roughly $165 million. The acquisition is expected to strengthen Flowers' snack cake business and expand its geographic reach. Tasty's stock more than doubled, gaining $2.35 to $3.96. Shares of Flower Foods were up 2.3% at $28.29.

Container shipping company Horizon Lines (HRZ) was up 13.7% on heightened volumes. The company has agreed to a settlement over business practices involving its cargo service with Puerto Rico. Horizon Lines is looking at options to refinance and restructure to avoid a debt default, according to press reports. Horizon has said it expects to default on its loans due to a $45 million fine for price-fixing in the Jacksonville-Puerto Rico trade lane.

Shares of dental laser manufacturer Biolase (BLTI), was up 7% at $6.16. The company announced Friday that it has executed an agreement for the sale of 320,000 shares of its common stock at $5.60 per share to institutional investors in a registered direct offering for approximately $1.80 million in gross proceeds.

Shares of Prana Biotech (PRAN) were up 5% at $2.52 after it said that it had secured a key patent for its PBT2 drug in Japan.

Rare metal stocks were once again in play with shares of Rare Element Resources (REE) and Avalon Rare Metals (AVL) gaining 10.3% and 7.5% respectively.

--Written by Shanthi Bharatwaj in New York

>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to

>To submit a news tip, send an email to:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
PRAN $1.13 0.00%
REE $0.76 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs